Dialysis Clinic competitors

Joseph 'Joe' Carlucci is a Board Member at Colorado Cntr Reproductive Med, CEO/Co-Founder at American Renal Holdings Inc, and Board Member at American Renal Holdings Inc. He has worked as Chairman/CEO/Co-Founder at AMERICAN RENAL ASSOCIATES HOLDINGS, INC.; COO/Treasurer/Co-Founder at American Renal Holdings Inc; and COO/Treasurer/Co-Founder at AMERICAN RENAL ASSOCIATES HOLDINGS, INC.. Joseph works or has worked as President/CEO at Optimal Renal Care. He studied at Bentley University.

An Evansville native, Shawn has served Deaconess for nearly 30 years, beginning his tenure as an industrial engineering summer intern. He held many different and varied management roles throughout his career, moving to the chief operating officer position in 2005. The Board unanimously selected him to succeed Linda White as the CEO of Deaconess Health System based on his intimate knowledge of the organization, his business acumen, ability to forge relationships with physicians, and his involvement in the community and non-profit organizations.

John Couris is a healthcare professional who has served as the president and chief executive officer of Tampa General Hospital since September 2017. John writes about leadership and the healthcare industry on his website www.leadingthechangewithjohncouris.com.

William Valle leads the globally operating Care Delivery segment, in which the company is combining its global healthcare services business effective January 1, 2022. Previously, he served as Chief Executive Officer for North America since February 17, 2017. Prior to that, he was Executive Vice President responsible for the dialysis service business and vascular access business of Fresenius Medical Care North America from 2014 to 2017. Bill joined Fresenius Medical Care in 2009 and has more than 30 years of experience in the dialysis industry, holding executive positions in sales, marketing and business development at several dialysis companies including Gambro Healthcare, Inc.

Robert 'Bob' Quattrocchi is a Chief Executive Officer at Northside Hospital.

Jeffrey Goffman is the CEO of Satellite Healthcare a National leading Kidney care company dedicated to making life better for those living with Kidney disease. Satellite has more than 85 locations across 5 states and provides in-center & home dialysis, a CVS Kidney partnership, clinical research & CKD care management focused on improving the quality and access to home dialysis care, reducing costs and implementing integrated value-based care. Goffman is the Vice Chairman of OneGI a Webster Equity portfolio company that is a gastroenterology management services organization that partners with GI physicians to help them manage, optimize & grow their practices and focus on providing excellent care to their patients. Goffman was the CEO of Integrated Oncology Network, LLC (“ION”) which he co-founded in 2008 until 2019. ION is a national oncology company that provides management services to its physician and hospital partners. ION owns more than 50 oncology centers across 17 states in partnership with approximately 300 physicians and 20 hospitals including some of the most prestigious healthcare systems in the US. Goffman was the CEO and Founder of OnCURE Medical Corp. (“OnCURE”) from its inception in 1998 until 2006 when it was sold. OnCURE was private equity sponsored and one of the largest providers of outpatient radiation oncology care in the United States with 40 centers owned and managed and affiliated with more than 100 physicians. Goffman was the CEO of U.S. Diagnostic, Inc. (“USD”), a leading consolidator of diagnostic imaging facilities. Goffman took USD public in 1994, and from inception until 1997 Goffman grew USD to 120 centers inGoffman is an inactive licensed Certified Public Accountant, member of the American Institute of Certified Public Accountants, and holds a Bachelor of Science degree in Accounting from the Barney School of Business at the University of Hartford. Goffman was inducted into the Barney School of Business Alumni Hall of Fame in 2014. Goffman is a member of the board of directors of several non-profit organizations including the American Cancer Society’s CEO’s Against Cancer and CureDuchenne.

Mark Caputo is the Chairman of the Board and Chief Executive Officer of U.S. Renal Care. Mark has spent the majority of his career building dialysis organizations focused on partnerships. Before joining U.S. Renal Care, Mark founded Liberty Dialysis in 2002 and served as its Chief Executive Officer, growing the business from a single clinic to the third-largest dialysis provider in the world, with 260 dialysis clinics serving 20,000 patients. In 2012, Liberty Dialysis merged with Fresenius Medical Care. Following the merger, Mark served as Managing Partner of Joint Ventures for Fresenius Medical Care, and then Chairman of the Board of Sound Physicians until June 2018. During his tenure as Chairman, Sound Physicians employed more than 3,500 hospital medicine physicians in 200 hospitals around the country. Mark received his M.B.A. from Harvard Business School and B.A. in Economics from Princeton University.